Molecular mechanisms of maculopapular exanthema

被引:37
作者
Fernandez, Tahia D. [1 ]
Canto, Gabriela [2 ]
Blanca, Miguel [3 ]
机构
[1] Carlos Haya Hosp, Fdn IMABIS, Allerg Dis Res Lab, Malaga, Spain
[2] Infanta Leonor Hosp, Allergy Serv, Madrid, Spain
[3] Carlos Haya Hosp, Allergy Serv, Malaga, Spain
关键词
chemokines; cytokines; oxidative stress; skin; T-lymphocytes; ALLERGIC REACTIONS; T-CELLS; HYPERSENSITIVITY REACTIONS; NONIMMEDIATE REACTIONS; CUTANEOUS REACTIONS; ATOPIC-DERMATITIS; DRUG-REACTIONS; YOUNG-ADULTS; CYTOKINE; SKIN;
D O I
10.1097/QCO.0b013e3283298e62
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Maculopapular exanthema is a common cutaneous manifestation of many diseases produced by several agents able to activate the immune system, the most common of which are drugs and viruses. In spite of its high frequency, knowledge of the molecular mechanisms involved remains scarce. Recent findings The cytokine patterns in maculopapular exanthema have a Th1 or Th0 pattern, according to whether the reaction is induced by a drug or a virus, respectively. Additionally, the involvement of CD4 T-lymphocytes with cytotoxic capabilities has been shown in the former. Different chemokines and their receptors are also involved in skin homing, such as CCL20, CCL27, CXCL9 or CXCL10, and oxidative stress can help exacerbate the symptoms. Summary These findings may be very important for the diagnostic evaluation of these entities and for the development of new tools for diagnosis and treatment.
引用
收藏
页码:272 / 278
页数:7
相关论文
共 53 条
[11]   Anti-oxidant enzyme activities and expression and oxidative damage in patients with non-immediate reactions to drugs [J].
Cornejo-Garcia, J. A. ;
Mayorga, C. ;
Torres, M. J. ;
Fernandez, T. D. ;
R-Pena, R. ;
Bravo, I. ;
Mates, J. M. ;
Blanca, M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 145 (02) :287-295
[12]  
DEWDENEY JM, 1997, ANTIGENS, V5, P73
[13]   Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis:: Signs of subset expansion and stimulation [J].
Dworzak, MN ;
Fröschl, G ;
Printz, D ;
Fleischer, C ;
Pötschger, U ;
Fritsch, G ;
Gadner, H ;
Emminger, W .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (05) :901-906
[14]  
Fernández FJF, 2007, AN MED INTERN, V24, P204
[15]   Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs [J].
Fernandez, T. D. ;
Mayorga, C. ;
Torres, M. J. ;
Cornejo-Garcia, J. A. ;
Lopez, S. ;
Chaves, P. ;
Rondon, C. ;
Blanca, M. .
ALLERGY, 2008, 63 (06) :712-719
[16]  
Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO
[17]  
2-S
[18]  
Gonzalez-Delgado Purificacion, 2006, Allergol Immunopathol (Madr), V34, P76, DOI 10.1157/13086752
[19]   T cell involvement in cutaneous drug eruptions [J].
Hari, Y ;
Frutig-Schnyder, K ;
Hurni, M ;
Yawalkar, N ;
Zanni, MP ;
Schnyder, B ;
Kappeler, A ;
Von Greyerz, S ;
Braathen, LR ;
Pichler, WJ .
CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (09) :1398-1408
[20]   Distinct serum cytokine levels in drug- and measles-induced exanthema [J].
Hari, Y ;
Urwyler, A ;
Hurni, M ;
Yawalkar, N ;
Dahinden, C ;
Wendland, T ;
Braathen, LR ;
Matter, L ;
Pichler, WJ .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 120 (03) :225-229